Carl Stefan Fraenkel
Director/Board Member at Akinion Pharmaceuticals AB
Carl Stefan Fraenkel active positions
| Companies | Position | Start | End |
|---|---|---|---|
Akinion Pharmaceuticals AB
 Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Akinion Pharmaceuticals AB operates as a holding company that focuses on the development of pharmaceutical for the treatment of acute myeloid leukemia. It develops, markets, and sells a product based on Biovitrum’s anti leukemia kinase inhibitor research. It is a drug development that manufactures a lead candidate drug, AKN-028, which is a small molecule kinase inhibitor. The company was founded by Vendela Parrow in 2009 and is headquartered in Solna, Sweden. | Director/Board Member | - | - |
Career history of Carl Stefan Fraenkel
Former positions of Carl Stefan Fraenkel
| Companies | Position | Start | End |
|---|---|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Corporate Officer/Principal | 23/02/2011 | - |
Training of Carl Stefan Fraenkel
| Copenhagen Business School | Doctorate Degree |
| Chalmers University of Technology | Undergraduate Degree |
Statistics
International
| Sweden | 4 |
| Denmark | 2 |
Operational
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
| Masters Business Admin | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
| Private companies | 1 |
|---|---|
Akinion Pharmaceuticals AB
Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Akinion Pharmaceuticals AB operates as a holding company that focuses on the development of pharmaceutical for the treatment of acute myeloid leukemia. It develops, markets, and sells a product based on Biovitrum’s anti leukemia kinase inhibitor research. It is a drug development that manufactures a lead candidate drug, AKN-028, which is a small molecule kinase inhibitor. The company was founded by Vendela Parrow in 2009 and is headquartered in Solna, Sweden. | Health Technology |
- Stock Market
- Insiders
- Carl Stefan Fraenkel
- Experience
